Key insights
- An analyst highlights Steven Mnuchin's attendance at a Lionsgate premiere with Apollo Global executives, suggesting potential M&A activity following prior deal talks. The analyst increased their stake in LGF ahead of a poison pill expiration, citing multiple catalysts. This could signal increased investor confidence in a potential acquisition or strategic deal, but the impact on broader US equities is limited.
Steven Mnuchin attended the LIONSGATE Studios premier of MICHAEL with two P/E equity executives in tow. Photos on the red carpet at the premiere this week show Steven Mnuchin mingling with Byron Vielehr of Apollo Global, COO. Byron is head of strategic business initiatives and this could be a follow-up to last year's Legendary mingling of a deal.
This timing follows July release https://variety.com/2025/film/news/legendary-lionsgate-studios-acquistion-deal-talks-1236453689/
I've rebought 150,000 shares heading into the poison pill expiration. There are too many catalysts here to avoid holding on at this time.